1HOLX Stock Overview

Engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. More details

1HOLX fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 61.5% below our estimate of its fair value

Earnings are forecast to grow 15.39% per year

Earnings grew by 19.2% over the past year

Analysts in good agreement that stock price will rise by 22.6%

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Hologic, Inc. Competitors

DiaSorin

BIT:DIA

€5.2b

EL.En

BIT:ELN

€729.1m

Amplifon

BIT:AMP

€4.3b

I.M.D. International Medical Devices

BIT:IMD

€24.6m

Price History & Performance

Summary of share price highs, lows and changes for Hologic
Historical stock prices
Current Share Price	US$47.00
52 Week High	US$0
52 Week Low	US$0
Beta	0.55
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-2.08%
Change since IPO	0.86%

Recent updates

Shareholder Returns

	1HOLX	IT Medical Equipment	IT Market
7D	-7.8%	-0.009%	2.1%
1Y	n/a	0.9%	12.2%

Return vs Industry: Insufficient data to determine how 1HOLX performed against the Italian Medical Equipment industry.

Return vs Market: Insufficient data to determine how 1HOLX performed against the Italian Market.

Price Volatility

Is 1HOLX's price volatile compared to industry and market?
1HOLX volatility
1HOLX Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.1%
Market Average Movement	5.3%
10% most volatile stocks in IT Market	8.7%
10% least volatile stocks in IT Market	3.4%

Stable Share Price: 1HOLX's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1HOLX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1985	7,063	Steve MacMillan	www.hologic.com

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
1HOLX fundamental statistics
Market cap	€10.46b
Earnings (TTM)	€492.12m
Revenue (TTM)	€3.56b

22.2x

P/E Ratio

3.1x

P/S Ratio

Is 1HOLX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1HOLX income statement (TTM)
Revenue	US$4.03b
Cost of Revenue	US$1.57b
Gross Profit	US$2.46b
Other Expenses	US$1.90b
Earnings	US$556.70m

Last Reported Earnings

Mar 29, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	2.50
Gross Margin	61.01%
Net Profit Margin	13.83%
Debt/Equity Ratio	54.5%

How did 1HOLX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/07 00:24
End of Day Share Price	2025/05/07 00:00
Earnings	2025/03/29
Annual Earnings	2024/09/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hologic, Inc. is covered by 51 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
David Toung	Argus Research Company
Ishan Majumdar	Baptista Research
Charles Butler	Barclays

Hologic BIT:1HOLX Stock Report